Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2305419 | 1.00 | NAAA (0.70) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL2305960 | 0.94 | TSHR (0.77) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL5362359 | 0.89 | HTT (0.86) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL11078107 | 0.89 | HTT (0.86) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL9260536 | 0.89 | HTT (0.86) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL11089468 | 0.89 | HTT (0.86) | NAAATSHRHTTHPGDALOX5 | |
| SCHEMBL7220254 | 0.87 | TSHR (0.61) | NAAATSHRHTTHPGDALDH1A1 | |
| SCHEMBL23610299 | 0.83 | HTT (0.75) | NAAATSHRHTTHPGDALDH1A1 | |
| SCHEMBL11089466 | 0.83 | HTT (0.75) | NAAATSHRHTTHPGDALDH1A1 | |
| SCHEMBL14483849 | 0.83 | HTT (0.75) | NAAATSHRHTTHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223453-B2 | Ink jet recording medium and ink jet recording method | FUJIFILM CORPORATION (JP) | 2007-05-29 | — | — | US | disclosed |
| EP-1525995-B1 | Inkjet recording method | FUJI PHOTO FILM CO LTD (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-7086726-B2 | Inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2006-08-08 | — | — | US | disclosed |
| EP-1525995-A1 | Inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-04-27 | — | — | EP | disclosed |
| US-20040166252-A1 | Ink jet recording medium and ink jet recording method | FUJI PHOTO FILM CO., LTD. | 2004-08-26 | — | — | US | disclosed |
| EP-1426194-A2 | Ink jet recording medium and ink jet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-6720421-B2 | STORAGE STABILITY: GOOD RAW-STOCK STORABILITY BEFORE RECORDING AND GOOD IMAGE STORABILITY AFTER RECORDING | FUJI PHOTO FILM CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20040012663-A1 | Inkjet recording method | FUJI PHOTO FILM CO., LTD. | 2004-01-22 | — | — | US | disclosed |
| EP-1352754-A2 | Inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030166961-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | FUJI PHOTO FILM CO., LTD. | 2003-09-04 | — | — | US | disclosed |
| US-20030064208-A1 | Inkjet recording sheet | FUJI PHOTO FILM CO., LTD. | 2003-04-03 | — | — | US | disclosed |
| EP-1260379-A2 | Inkjet recording sheet | FUJI PHOTO FILM CO., LTD. (JP) | 2002-11-27 | — | — | EP | disclosed |
| US-20020161225-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | FUJI PHOTO FILM CO., LTD. | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166961-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | UROD, ATIC, DDC | NAAA 245/4885TSHR 4195/4885HTT 2905/4885 |
| US-20020161225-A1 | Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative | UROD, ATIC, DDC | NAAA 245/4885TSHR 4195/4885HTT 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.